Vnitřní lékařství, 1971 (roč. 17), číslo 2

[Heavy chain disease (gamma). I. Clinical and pathologico-anatomical part].

J Jedlicková, Z Churý, P Jansa, L Rozprimová, J Sabacký

Vnitr Lek 1971, 17(2):105-110

[Heavy chain disease (gamma). II. Special studies].

J Sabacký, L Rozprimová, J Jedlicková, Z Churý

Vnitr Lek 1971, 17(2):111-118

[Influence of atherogenic diet on the development of antibodies against aorta and liver in rabbits].

F Melichar, M Skálová

Vnitr Lek 1971, 17(2):119-125

[Incidence of chronic bronchitis in the Most region].

F Boudík, V Teichman, J Ulrich, F Svec, J Stach, L Preiningerová

Vnitr Lek 1971, 17(2):126-134

[Influence of increased salt intake on the excretion of osmotically active substances and water by kidney. Comparison with the limited effect of dietary sodium].

J Stríbrná, E Kuhn, O Schück, V Brodan, J Válek

Vnitr Lek 1971, 17(2):135-146

[Changes of Hippuran renographic curve following the use of phenylbutazone, Spofa].

A Huvar, J Sitar

Vnitr Lek 1971, 17(2):147-153

[Treatment with nicotinic acid of patients with ischemic heart disease and hypercholesterolemia. II. Influence on the liver].

M Kubasta, J Nizník, V Jezdinská, J Vrána, H Vaverková, R Podivínský, A Zmeskal

Vnitr Lek 1971, 17(2):154-162

[Physiology of reticuloendothelial system (RES)].

P Jansa

Vnitr Lek 1971, 17(2):163-169

[Allergo-toxic disturbances of the heart muscle with congestive heart failure as a result of parenteral treatment with phenylbutazone].

A Tovarys, E Brunová

Vnitr Lek 1971, 17(2):170-174

[Sudden ischemic cerebrovascular accident as a sign of malignant tumor].

M Zuffa

Vnitr Lek 1971, 17(2):175-181

[Routine fluorometric determination of nonconjugated corticosteroid substances in blood plasma].

J Bumba, A Janícek

Vnitr Lek 1971, 17(2):182-186